Remove Pharmaceuticals Remove Regulations Remove White Paper
article thumbnail

Leveraging FSP Solutions and Expertise to Keep Up With Regulatory Intelligence Systems Monitoring

PPD

Effective monitoring of regulatory intelligence comes with big challenges The challenges inherent to PV RI encompass more than just regulatory complexity — though complexity is a major factor, given regulations are continually created, updated or revised, at all levels (regional, national and global), often all at the same time.

article thumbnail

Five ways to optimize water monitoring in pharma

The Pharma Data

Discover five good manufacturing practices for water monitoring and sanitization for pharmaceutical use. The control of water quality throughout the manufacturing lifecycle of a product, including storage and distribution, is a major focus for compliance regulators. Add bookmark. Download Your Copy. Download Your Copy.

article thumbnail

Optimizing pharma water monitoring in real-time to maintain production cycles

The Pharma Data

Learn about new solutions for real-time and thorough monitoring of pharmaceutical water systems to ensure only the highest quality products are delivered to patients. Download Mettler Toledo’s white paper for: Insights on how to meet the demands of ever-stricter water testing regulations head on. Add bookmark.

article thumbnail

Five ways to ensure pharma water is GMP compliant

The Pharma Data

. The control of water quality throughout the manufacturing lifecycle of a product, including storage and distribution, is a major focus for compliance regulators. Download Mettler Toledo’s Pharmaceutical Waters white paper to discover how to: Monitor water for injection in real-time.

article thumbnail

Compliant Science: The Critical Role of Compliance for Medical Affairs

H1 Blog

But in today’s highly regulated environment, it is more important than ever to make sure that HCP engagement plans are compliant with anti-kickback laws. Since KOLs play such a critical role, engaging with the right KOLs is a key strategy for pharmaceutical companies to stay ahead of the game.

article thumbnail

Analysis Life Sciences Thank You CDER’s Office of Pharmaceutical Quality to reorganize, citing need to address ‘pain points’

Agency IQ

BY ALEXANDER GAFFNEY, MS, RAC | NOV 9, 2023 6:35 PM CST Background on CDER’s Office of Pharmaceutical Quality (OPQ) CDER’s Office of Pharmaceutical Quality became operational in January 2015, making it a still relatively recent addition to the agency. Read AgencyIQ’s analysis of FDA’s QMM White Paper here.]

article thumbnail

Analysis Life Sciences Thank You What is the state of pharmaceutical quality in the U.S.? Call it murky

Agency IQ

What is the state of pharmaceutical quality in the U.S.? Call it murky A new report published by the FDA’s Office of Pharmaceutical Quality (OPQ) promises a look at the current “State of Pharmaceutical Quality.” Read AgencyIQ’s analysis of FDA’s QMM White Paper here.]